However, while the use of SMBG in patients with type 1 diabetes (T1DM) has been associated with improved health outcomes, the evidence base for the impact of SMBG on patients with type 2 diabetes (T2DM), especially those not on insulin, has been conflicting [5]. Here, INS is linked to type 2 diabetes mellitus.